Vir Biotechnology, Inc.

NASDAQ:VIR

9.87 (USD) • At close November 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -615.061515.837528.584-298.665-174.683-115.884-69.852
Depreciation & Amortization 19.4516.7835.8115.4424.5172.7560.432
Deferred Income Tax -1.063-15.18615.186-0.05214.664-0.48-10.924
Stock Based Compensation 111.316102.08283.78427.68.7195.0534.782
Change In Working Capital -304.591665.367-628.39429.5228.20412.4944.862
Accounts Receivables -0.565770.038-773.0790000
Inventory 0052.8150000
Accounts Payables 0.7320.797-0.171-0.790.9641.4712.011
Other Working Capital -304.758-105.46892.04130.3127.2411.0232.851
Other Non Cash Items 11.163388.37-52.5645.2128.9471.9654.319
Operating Cash Flow -778.7851,663.253-47.589-190.941-129.632-94.096-66.381
Investing Activities:
Investments In Property Plant And Equipment -21.573-68.028-21.817-6.549-8.94-8.192-2.742
Acquisitions Net 0.10.022140.8140.18247.2180.025-27.252
Purchases Of Investments -2,016.189-1,476.965-420.24-403.841-643.898-123.1050
Sales Maturities Of Investments 2,202.391351.51301.243400.348396.6872.5740
Other Investing Activites 186.202-1,125.455-140.8140.18-247.218-1.7430
Investing Cash Flow 164.729-1,193.461-140.814-9.862-256.158-60.441-29.994
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 7.76736.218100.59529.913126.41124.978271.182
Common Stock Repurchased 03.22200-0.00300
Dividends Paid 0000000
Other Financing Activities -0.135.021100.59-0.189322.93124.978271.182
Financing Cash Flow 7.3834.761100.331529.474449.24424.978271.182
Other Information:
Effect Of Forex Changes On Cash -7.48000000
Net Change In Cash -606.468504.553-88.072328.67163.454-129.559174.807
Cash At End Of Period 254.844867.968363.415451.487122.81659.362188.921